These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hepatobiliary MR imaging: first human experience with MnDPDP. Lim KO; Stark DD; Leese PT; Pfefferbaum A; Rocklage SM; Quay SC Radiology; 1991 Jan; 178(1):79-82. PubMed ID: 1898539 [TBL] [Abstract][Full Text] [Related]
24. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Grant D; Blazak WF; Brown GL Acta Radiol; 1997 Jul; 38(4 Pt 2):759-69. PubMed ID: 9245972 [TBL] [Abstract][Full Text] [Related]
25. Sequence optimization in mangafodipir trisodium-enhanced liver and pancreas MRI. Wang C; Johansson L; Western A; Fagertun H; Ahlström H J Magn Reson Imaging; 1999 Feb; 9(2):280-4. PubMed ID: 10077025 [TBL] [Abstract][Full Text] [Related]
26. Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart. Brurok H; Berg K; Sneen L; Grant D; Karlsson JO; Jynge P Invest Radiol; 1999 Jul; 34(7):470-6. PubMed ID: 10399637 [TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging after arterial portography with manganese dipyridoxal diphosphate. Nelson RC; Chezmar JL; Thompson GH; Webber JB; Garrison MH; Spencer HB; Dillehay DL Invest Radiol; 1993 Apr; 28(4):335-40. PubMed ID: 8478175 [TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions. Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944 [TBL] [Abstract][Full Text] [Related]
30. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs. Jung G; Heindel W; Krahe T; Kugel H; Walter C; Fischbach R; Klaus H; Lackner K Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775 [TBL] [Abstract][Full Text] [Related]
31. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR. Schmidt PP; Toft KG; Skotland T; Andersson K J Biol Inorg Chem; 2002 Mar; 7(3):241-8. PubMed ID: 11935348 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs. Toft KG; Hustvedt SO; Grant D; Friisk GA; Skotland T Eur J Drug Metab Pharmacokinet; 1997; 22(1):65-72. PubMed ID: 9179562 [TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). Federle MP; Chezmar JL; Rubin DL; Weinreb JC; Freeny PC; Semelka RC; Brown JJ; Borello JA; Lee JK; Mattrey R; Dachman AH; Saini S; Harmon B; Fenstermacher M; Pelsang RE; Harms SE; Mitchell DG; Halford HH; Anderson MW; Johnson CD; Francis IR; Bova JG; Kenney PJ; Klippenstein DL; Foster GS; Turner DA J Magn Reson Imaging; 2000 Jul; 12(1):186-97. PubMed ID: 10931579 [TBL] [Abstract][Full Text] [Related]
34. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606 [TBL] [Abstract][Full Text] [Related]
35. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks]. Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779 [TBL] [Abstract][Full Text] [Related]
36. Thallium-like test for myocardial viability with MnDPDP-enhanced MRI. Wendland MF; Saeed M; Bremerich J; Arheden H; Higgins CB Acad Radiol; 2002 May; 9 Suppl 1():S82-3. PubMed ID: 12019904 [No Abstract] [Full Text] [Related]
37. Uptake of MnCl2 and mangafodipir trisodium in the myocardium: a magnetic resonance imaging study in pigs. Eriksson R; Johansson L; Bjerner T; Briley Saebo K; Ahlström H J Magn Reson Imaging; 2004 May; 19(5):564-9. PubMed ID: 15112305 [TBL] [Abstract][Full Text] [Related]
38. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging. Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580 [TBL] [Abstract][Full Text] [Related]
39. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging. Gong J; Xu J; Zhou K; Shen K Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113 [TBL] [Abstract][Full Text] [Related]
40. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]